Parkinson's Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinical diagnosis confirmed by a neurologist following the Movement Disorder Society criteria; both sexes; residents of Florianópolis and São José; on stable doses of medication for the last four weeks; on ON medication; aged 45 years or over; not practicing physical exercise in the month prior to data collection; classified in stages 1 to 4 of PD by the Hoehn & Yahr Disability Scale
Exclusion criteria
Exclusion criteria: Cutoff point of the Montreal Cognitive Assessment (MoCA) instrument for screening, considering = 22 points; classified in stage 5 of PD by the HY Disability Scale; who did not complete all stages of the study; who performed other physical exercise concomitantly; who were not present in up to 75% of the classes.date for enrollment of the first participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Using the Parkinson's Disease questionnaire method (PDQ 39), it is expected to evaluate the quality of life of people with Parkinson's after interventions. This instrument provides information on the impact of the disease in eight dimensions (mobility, activities of daily living, emotions, stigma, social, cognition, communication and body pain). There are 39 items ranging from 0 (never) to 4 (always) and a maximum score of 100 points. The higher the value, the worse the quality of life (Jenkinson et al., 1997) | — |
Secondary
| Measure | Time frame |
|---|---|
| Using the Unified Parkinson's Disease Rating Scale (UPDRS), it is expected to analyze general symptoms. The UPDRS evaluates several aspects of Parkinson's disease. Considered the gold standard assessment method and frequently used for clinical and research purposes. Consisting of 42 questions and divided into four parts: 1- Mental state, behavior and emotional state; 2- Activities of daily living; 3- Motor exploration and 4- Therapy complications. The score on this scale varies between 0 and 199, with a lower score being an indicator of less severity and a higher score being an indicator of greater symptom severity (“The Unified Parkinson’s Disease Rating Scale (UPDRS): Status and recommendations”, 2003);By using the goniometer and presenting this result, we hope to verify whether the range of movement of the shoulders improved after the interventions.To assess shoulder flexion, the person will be in the supine position, placing the fixed arm of the goniometer in the mid-axillary line of the trunk, pointing towards the greater trochanter of the femur, the movable one on the lateral surface of the body of the humerus facing the lateral epicondyle and the axis close to the acromion. During abduction, the patient will be assessed standing with one of the arms extended, with the goniometer fixed arm on the posterior axillary line of the trunk, the movable arm on the posterior surface of the arm and the axis close to the acromion. During extension, you will also be standing with one of your arms extended, with the fixed arm of the goniometer in the mid-axillary line pointing towards the greater trochanter of the femur, the mobile placed on the lateral surface of the body of the humerus facing the lateral epicondyle and the lateral axis. lateral side of the glenohumeral joint. According to the Goniometry Manual, Measurement of Joint Angles (2016);With the use of the goniometer and presentation of this result, it is expected to verify whether the range of hip movement, ass | — |
Countries
Brazil
Contacts
Universidade do Estado de Santa Catarina